Prevention of upper respiratory tract infections in high performance athletes with Plesinox 3A.

Clinical experience with Plesinox in recurrent infections referred for ent consultations.

Evaluation of the activity of EPL and EPL+vitamins in human peripheral blood monocyte-macrophage cells.

Immunomodulatory effect of Polypodium leucotomos (Anapsos) in child palatine tonsil model.

Tonsillopharyngitis chronic in children. Reply with anapsos.

Anapsos use in the treatment of chronic recurrent pharyngo-tonsillitis.

Assessment of anapsos activity in children with pharyngotonsillitis by reducing the number of tonsillectomy.

New clinical experience with Plesinox 3A in recurrent pediatric pathology with special attention to PFAPA syndrome.

logo plesinox 3A

Distributed by:

Especialidades Farmacéuticas CENTRUM, S.A.

RGSEAA: 26.09272/A

C/ Sagitario, 14. 03006 Alicante – España